Why Patients Switch Between These Leading GLP-1 Treatments
Understanding Your 1mg Wegovy to Mounjaro Switching Options
The decision to switch from 1mg Wegovy to Mounjaro represents a significant consideration in your weight management journey. At the 1mg dose level—typically weeks 9-12 of treatment—many patients have established their response pattern and may be evaluating alternatives for various reasons. Some experience different side effect profiles, others seek cost advantages, while some prefer Mounjaro's dual GIP/GLP-1 mechanism over Wegovy's single GLP-1 approach. The approximate equivalent to 1mg Wegovy would be Mounjaro's 5mg maintenance dose, though your prescriber will determine the most appropriate transition protocol.
EverydayMeds simplifies this comparison by stocking both treatments through our GPhC-registered pharmacy (#9012878), eliminating the need to switch providers when changing medications. Our clinical team understands the nuances of transitioning between semaglutide (Wegovy) and tirzepatide (Mounjaro), ensuring continuity of care throughout your switch. Whether you're moving from 1mg Wegovy to Mounjaro or considering the reverse transition, we provide the clinical oversight and pharmaceutical expertise to make informed decisions about your prescription-only medicine needs.
1mg Wegovy to Mounjaro: Pricing Comparison and Savings
Cost considerations often influence the decision to switch from 1mg Wegovy to Mounjaro, with transparent pricing helping you make informed financial decisions. Our 1mg Wegovy costs £99.99 per pen after applying discount codes at checkout—FIRST40 for new customers or DOSE25 for returning patients. The equivalent Mounjaro doses offer different pricing structures, and our bundle options like the Consistency 1mg bundle (two pens for £209.99) provide extended supply convenience. These prices represent the final amounts you'll pay, with discount codes applied during the checkout process.
When comparing 1mg Wegovy to Mounjaro equivalents, consider not just individual pen costs but also your long-term treatment plan and potential insurance coverage differences. Our Advance Duo bundle pairs 1mg with 1.7mg for £269.99, supporting patients who plan to continue dose escalation regardless of which medication they choose. The financial aspect of switching from 1mg Wegovy to Mounjaro becomes clearer when you factor in our consistent pricing across both treatments, eliminating the uncertainty often associated with changing pharmacy providers mid-treatment.
Clinical Evidence Supporting Both Treatment Options
The STEP trials demonstrated that patients taking Wegovy alongside diet and exercise achieved approximately 15% average weight loss at 68 weeks compared to 2.4% with placebo (Wilding et al., NEJM, 2021). At the 1mg dose level, patients typically begin experiencing the more pronounced appetite suppression effects that contribute to these outcomes. The clinical evidence suggests that by weeks 9-12, when 1mg dosing occurs, significant biological changes in appetite regulation may become apparent.
Mounjaro's clinical trials showed comparable efficacy through its dual GIP/GLP-1 receptor mechanism, though direct head-to-head comparisons between 1mg Wegovy to Mounjaro aren't available due to different trial designs and patient populations. Both medications require prescription-only access and work best alongside a reduced-calorie diet and increased physical activity. Your prescriber can evaluate which treatment option aligns with your individual response pattern and clinical needs when considering a switch from 1mg Wegovy to Mounjaro.
How Wegovy's Mechanism Compares at the 1mg Dose Level
Wegovy functions as a GLP-1 receptor agonist, mimicking the natural incretin hormone that signals satiety to your brain's appetite control centres. At the 1mg dose—your current stage in the escalation protocol—this mechanism typically demonstrates more pronounced effects compared to the earlier 0.25mg and 0.5mg doses. The medication works by slowing gastric emptying, increasing feelings of fullness after smaller meals, and potentially reducing food cravings through direct action on hypothalamic appetite centres. Unlike Mounjaro's dual GIP/GLP-1 approach, Wegovy focuses exclusively on GLP-1 pathway activation. This single-target mechanism has been extensively studied in the STEP trial programme, providing robust clinical evidence for its weight management effects when used as a prescription-only medicine alongside lifestyle modifications.
Seamless Ordering Process for Treatment Transitions
Switching from 1mg Wegovy to Mounjaro through EverydayMeds requires completing our 3-minute online clinical assessment, which captures your current treatment history and reasons for switching. Our prescribers conduct thorough reviews within 3 working days (or 24 hours with express service) to ensure safe transition protocols and appropriate dose equivalency. Once approved, your new prescription ships via next-day cold-chain delivery, maintaining the temperature-controlled storage requirements essential for both medications. The entire process eliminates the complexity typically associated with changing treatments mid-course. Our clinical team coordinates your switch timing to minimise treatment gaps, ensuring continuity in your weight management programme whether transitioning to or from 1mg Wegovy to Mounjaro equivalent doses.
Storage and Practical Considerations When Switching
Both Wegovy and Mounjaro require refrigeration at 2-8°C before first use, though Wegovy offers superior travel convenience with 6 weeks of room temperature stability below 30°C compared to Mounjaro's 21-day limit. The 1mg Wegovy FlexTouch pen delivers consistent dosing through its established injection mechanism, while Mounjaro uses a different pen design that some patients prefer. When switching from 1mg Wegovy to Mounjaro, you'll need to familiarise yourself with the new injection technique, though both are designed for once-weekly subcutaneous administration. Consider your travel patterns, storage limitations, and injection preferences when evaluating the switch. The dose escalation schedules differ between treatments, so your prescriber will provide specific guidance on timing your transition to maintain therapeutic continuity while minimising potential side effects.
Why the 1mg Stage Is Optimal for Treatment Switching
The 1mg Wegovy dose represents an ideal switching point because you've completed the initial tolerance-building phases while remaining below the higher maintenance doses where treatment interruption becomes more challenging. At this stage, you have sufficient experience with GLP-1 effects to make informed comparisons with Mounjaro's dual mechanism approach. Most patients at the 1mg level have established their side effect profile and response patterns, providing valuable information for prescribers evaluating alternative treatments. The timing also allows for strategic cost planning, as you can compare the financial implications of continuing Wegovy escalation versus transitioning to Mounjaro's dosing schedule.
Switching from 1mg Wegovy to Mounjaro at this stage offers flexibility in your treatment journey without compromising momentum. Your appetite regulation mechanisms are sufficiently established to maintain progress during the transition period, while the dose equivalency calculations remain straightforward for prescribers. This represents a natural decision point where treatment modifications can be implemented safely and effectively under proper clinical supervision.
Complete Your Treatment Switch Today
Ready to explore switching from 1mg Wegovy to Mounjaro, or comparing both options side-by-side? Start with our comprehensive clinical assessment at https://everydaymeds.co.uk/collections/weight-loss, where our prescribers can evaluate your individual switching requirements and provide personalised guidance. Apply discount code FIRST40 for new customers or DOSE25 for returning patients to access our competitive pricing on both treatments. Our GPhC-registered pharmacy (#9012878) ensures consistent quality and clinical oversight whether you're continuing with 1mg Wegovy or transitioning to Mounjaro equivalents. Don't let uncertainty about treatment options delay your progress—our clinical team specialises in helping patients navigate these important therapeutic decisions. With next-day delivery and comprehensive support, switching treatments has never been more accessible or professionally managed.
Reviewed by the EverydayMeds Clinical Team · GPhC #9012878 · Last updated February 2026
